when were glp 1 agonists approved for weight loss History of GLP-1 Medications Orforglipron, an Oral Small-Molecule GLP-1
Description
Evaluate the benefits and concerns surrounding GLP-1 treatments
Important Safety Information for GLP-1 Medications
Its cognitive-support properties have been extensively studied
Research shows that nearly 90% of people with type 2 diabetes also struggle with their weight, and these medications solve both problems at once
DPP-4 inhibitors were introduced for the treatment of type 2 diabetes in 2006
Researchers assess whether GLP-1 receptor agonists increase the risk of suicide, self-harm, or suicidal ideation in type 2 diabetes patients.
